Myeloid sarcoma concurrent with de novo KMT2A gene-rearranged infantile acute lymphoblastic leukemia

被引：1

作者：

Abe, Hitomi ^{[1
]}

Hamada, Satoru ^{[1
,2
]}

Sakiyama, Hideki ^{[1
]}

Oshiro, Tokiko ^{[1
,2
]}

Kato, Miho ^{[3
]}

Yagi, Takeshi ^{[3
]}

Matsuda, Takehiro ^{[3
]}

Higa, Takeshi ^{[3
]}

Hyakuna, Nobuyuki ^{[1
,2
]}

Nakanishi, Koichi ^{[1
,2
]}

机构：

[1] Univ Ryukyus Hosp Uehara, Dept Pediat, Nishihara, Okinawa, Japan

[2] Univ Ryukyus Uehara, Grad Sch Med, Dept Child Hlth & Welfare, Nishihara, Okinawa, Japan

[3] Okinawa Prefectural Nanbu Med Ctr, Dept Pediat Hematol & Oncol, Childrens Med Ctr, Haebaru, Okinawa, Japan

来源：

PEDIATRIC BLOOD & CANCER | 2022年 / 69卷 / 04期

关键词：

GEMTUZUMAB OZOGAMICIN; AML;

D O I：

10.1002/pbc.29573

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 8 条

[1] Gemtuzumab Ozogamicin Therapy for Isolated Extramedullary AML Relapse after Allogeneic Hematopoietic Stem-Cell Transplantation [J].

Ando, Toshihiko ;

Mitani, Noriyuki ;

Matsunaga, Kimie ;

Nakazora, Tatsuki ;

Gondo, Toshikazu ;

Yujiri, Toshiaki ;

Tanizawa, Yukio .

TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2010, 220 (02) :121-125

[2] How I treat extramedullary acute myeloid leukemia [J].

Bakst, Richard L. ;

Tallman, Martin S. ;

Douer, Dan ;

Yahalom, Joachim .

BLOOD, 2011, 118 (14) :3785-3793

[3] Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome [J].

Chang, H ;

Brandwein, J ;

Yi, QL ;

Chun, K ;

Patterson, B ;

Brien, B .

LEUKEMIA RESEARCH, 2004, 28 (10) :1007-1011

[4] Allogeneic Hematopoietic Stem-Cell Transplantation for Myeloid Sarcoma: A Retrospective Study From the SFGM-TC [J].

Chevallier, Patrice ;

Mohty, Mohamad ;

Lioure, Bruno ;

Michel, Gerard ;

Contentin, Nathalie ;

Deconinck, Eric ;

Bordigoni, Pierre ;

Vernant, Jean-Paul ;

Hunault, Mathilde ;

Vigouroux, Stephane ;

Blaise, Didier ;

Tabrizi, Reza ;

Buzyn, Agnes ;

Socie, Gerard ;

Michallet, Mauricette ;

Volteau, Christelle ;

Harousseau, Jean-Luc .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (30) :4940-4943

[5] Treatment of myeloid sarcoma without bone marrow involvement with gemtuzumab ozogamicin-containing regimen [J].

Ibrahim, Moayed ;

Chen, Rebecca ;

Vegel, Andrew ;

Panse, Ketaki ;

Bhyravabhotla, Kshama ;

Harris, Kendra ;

Craig, Ryan ;

Safah, Hana ;

Saba, Nakhle S. ;

Socola, Francisco .

LEUKEMIA RESEARCH, 2021, 106

[6] Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas [J].

Piccaluga, PP ;

Martinelli, G ;

Rondoni, M ;

Malagola, M ;

Gaitani, S ;

Isidori, A ;

Bonini, A ;

Gugliotta, L ;

Luppi, M ;

Morselli, M ;

Sparaventi, G ;

Visani, G ;

Baccarani, M .

LEUKEMIA & LYMPHOMA, 2004, 45 (09) :1791-1795

[7] A risk-stratified therapy for infants with acute lymphoblastic leukemia: a report from the JPLSG MLL-10 trial [J].

Tomizawa, Daisuke ;

Miyamura, Takako ;

Imamura, Toshihiko ;

Watanabe, Tomoyuki ;

Saito, Akiko Moriya ;

Ogawa, Atsushi ;

Takahashi, Yoshihiro ;

Hirayama, Masahiro ;

Taki, Tomohiko ;

Deguchi, Takao ;

Hori, Toshinori ;

Sanada, Masashi ;

Ohmori, Shigeru ;

Haba, Masami ;

Iguchi, Akihiro ;

Arakawa, Yuki ;

Koga, Yuhki ;

Manabe, Atsushi ;

Horibe, Keizo ;

Ishii, Eiichi ;

Koh, Katsuyoshi .

BLOOD, 2020, 136 (16) :1813-1823

[8] MLL-Rearranged Leukemias-An Update on Science and Clinical Approaches [J].

Winters, Amanda C. ;

Bernt, Kathrin M. .

FRONTIERS IN PEDIATRICS, 2017, 5

← 1 →